Approximately 30% of patients with head and neck squamous cell carcinoma (HNSCC) are
at least 70 years of age, and this percentage is expected to increase as the population …

Importance The number of older adults with head and neck squamous cell carcinoma
(HNSCC) is increasing, and these patients are underrepresented in clinical trials. It is …

Background Lymph node metastasis (LNM) is an important cause leading to recurrence and
development of head and neck carcinoma (HNC), with the precise mechanisms unclear …

Introduction The underlying factors that contribute to early radiotherapy (RT) termination are
understudied, especially in the era of hypofractionated treatment regimens. In this …

The incidence of human papillomavirus (HPV) associated oropharyngeal squamous cell
carcinoma (OPSCC) is increasing among elderly (≥ 70 years) patients and the optimal …

Purpose The number of older adults with head and neck squamous cell carcinoma
(HNSCC) is continuously increasing. Older HNSCC patients may be more vulnerable to …

Treatment of patients with squamous cell carcinoma of the head and neck region (HNSCC)
is in focus of a multitude of studies. In those, one patient group, aging 76 and more is mostly …

Objective To determine the rate of inadequate radiotherapy and identify risk factors
associated with inadequate adjuvant radiotherapy for head and neck cancer among older …

Objective Characterizing factors associated with palliative care (PC) use in patients with
stage III and VI head and neck cancer using Anderson's behavioral model of health service …

The use of PD-1 immune checkpoint inhibitor medications has become a common practice
in the treatment of recurrent and metastatic head and neck squamous-cell carcinomas …